Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001610717-24-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-01-04 | 2024-01-02 | ANTX | Easom Eric | CEO, Dir | S - Sale | $20.09 | -2,777 | 2,130 | -57% | -$55.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 2,777 | $20.09 | 2,130 | D | — | — |